- Argentina
- Finland
- Japan
- Senegal
- France
- Korea
- Slovakia
- Australia
- Germany
- Malaysia/Singapore
- South Africa
- Austria
- Greece
- Mexico
- Spain
- Belgium
- Hong Kong
- Netherlands
- Sweden
- Brazil
- Hungary
- New Zealand
- Switzerland
- Canada
- India
- Norway
- Taiwan
- China
- Indonesia
- Pakistan
- Thailand
- Colombia
- Ireland
- Philippines
- Turkey
- Czech Republic
- Israel
- Poland
- United Kingdom
- Denmark
- Italy
- Portugal
- Venezuela
The Pfizer Board: Corporate Governance Committee
Under the terms of its Charter, the Corporate Governance Committee is responsible for considering and making recommendations to the Board concerning the appropriate size, function and needs of the Board.
| Board Member | Independent | Position |
|---|---|---|
| Dennis A. Ausiello | Yes | Member |
| M. Anthony Burns | Yes | Member |
| William H. Gray III | Yes | Chair |
| Helen H. Hobbs | Yes | Member |
| Constance J. Horner | Yes | Member |
| John P. Mascotte | Yes | Member |
| Stephen W. Sanger | Yes | Member |
 |
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page. |
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Health Care Professionals
- Privacy Policy
Copyright © 2002–2012 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc. is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.